Viewing StudyNCT05261646



Ignite Creation Date: 2024-05-06 @ 5:19 PM
Last Modification Date: 2024-10-26 @ 2:26 PM
Study NCT ID: NCT05261646
Status: WITHDRAWN
Last Update Posted: 2023-09-28
First Post: 2022-02-21

Brief Title: A Clinical Study of Hetrombopag Olamine Tablets in Adults Receiving 21-day Cycles of Chemotherapy for Solid Tumours Who Are Delayed for at Least 1 Week From Their Scheduled Cycle Because of Chemotherapy-induced Thrombocytopenia
Sponsor: Jiangsu HengRui Medicine Co Ltd
Organization: Jiangsu HengRui Medicine Co Ltd

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-04-15
Start Date Type: ESTIMATED
Primary Completion Date: 2025-03-15
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-12-15
Completion Date Type: ESTIMATED
First Submit Date: 2022-02-21
First Submit QC Date: February 21 2022
Study First Post Date: 2022-03-02
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-09-25
Last Update Post Date: 2023-09-28
Last Update Post Date Type: ACTUAL